COUNTERPOINT: Is Monitoring Drug Levels Clinically Useful in the Management of Patients With Nontuberculous Mycobacterial Lung Disease? No

2026-08-10

PRE

David J. Epstein *

DOI：10.1016/j.chest.2026.02.048

Original request for help

Save

Abstract

IF:

8.6

Papers:

4.9W

Citations:

5.1W

No organization information available